Zymeworks Inc.
ZYME:NYSE; ZYME:TSX
Zymeworks is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. The company's suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates.
Streetwise Company Fact Sheet2024/11/23 9:07:52
(ZYME:NYSE - ZYME:TSX)
Analyst coverage
| Wells Fargo & Co. — Derek Achila |
| H.C. Wainwright & Co. — Robert Burns |
| J.P. Morgan — Brian Cheng |
| Bloom Burton & Co. — David Martin |
| Evercore — Jon Miller |
| Citi — Yigal Nochomovitz |
| H.C. Wainwright & Co. — Dr. Ram Selvaraju |
| Jefferies & Co. — Akash Tewari |
| Stifel — Stephen Willey |
Streetwise Reports Articles
| 09/25/2024 - View Article |
© 2024 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
